Circle Pharma, a clinical-stage biopharmaceutical company advancing macrocycle therapeutics for difficult-to-treat cancers, today announced the presentation of preclinical data on CID-078 at the ...

RHEACELL announced today that it has entered into an exclusive partnership agreement with the AOP Health Group, who will commercialize RHEACELL's two stem cell products, EBESANAR® and AMESANAR®, in ...

A former surgeon and healthcare executive, Dr. Harry Moon steps into leadership at Nova Southeastern University at a critical ...

Plus, hedge fund investor Ken Griffin gave $10 million to NYU Langone Health to create a center that will offer programs ...

This designation is meaningful as it signifies our continued commitment to making biosimilars more accessible. Both biosimilars and interchangeable biosimilars are highly similar and have no ...

Bildnachweis: Life Science Factory, Avocet Bio, VC Magazin, Pixabay. The Life Science Factory offers founders from research ...

CBI issues Interpol Silver Notices for visa fraud and unauthorized cryptocurrency cases, seeking global cooperation in ...

LAMR trades at 13.7x AFFO with a 5.36% yield, offering attractive total return potential given resilient fundamentals and ...

As part of a $93 million grant package, the Cancer Prevention and Research Institute of Texas, known for funding ...

Occidental Petroleum shines with Permian Basin strength, low-carbon tech, Buffett's backing, and growth potential. Read why I ...

MUMBAI, India, NAPLES, Fla. and CHICAGO, May 27, 2025 /PRNewswire/ -- Global pharma major Lupin Limited (Lupin) will present data from its Phase 1 ...

The Trump administration asked federal agencies Tuesday to cancel contracts with Harvard University worth about $100 million, ...